Qube Research & Technologies LTD Precigen, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $14,645 - $26,062	11,532 New	11,532 $17,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $621,879 - $1.37 Million	-540,765 Reduced 90.33%	57,921 $78,000
Q1 2022 May 09, 2022	BUY	$1.91 - $3.98 $999,363 - $2.08 Million	523,227 Added 693.39%	598,686 $1.26 Million
Q4 2021 Feb 01, 2022	SELL	$3.53 - $5.5 $81,172 - $126,472	-22,995 Reduced 23.36%	75,459 $280,000
Q3 2021 Nov 12, 2021	BUY	$4.99 - $6.55 $408,162 - $535,763	81,796 Added 491.03%	98,454 $491,000
Q2 2021 Aug 13, 2021	SELL	$6.24 - $8.22 $233,650 - $307,789	-37,444 Reduced 69.21%	16,658 $109,000
Q1 2021 May 14, 2021	BUY	$6.74 - $10.95 $364,647 - $592,416	54,102 New	54,102 $373,000

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.